Key Takeaways
- India's leprosy elimination efforts face challenges due to ongoing transmission and uneven disease burden.
- The government's commitment to leprosy elimination is crucial, and the implementation of effective strategies will be essential in reducing the disease burden.
- Readers in India can contribute to the efforts by supporting awareness campaigns, promoting community engagement, and advocating for improved healthcare infrastructure in endemic areas.
What happened
India has seen a decline in leprosy prevalence over the last decade, but the disease continues to spread in many areas, hindering the country's ability to meet its National Strategic Plan (NSP) and Roadmap for Leprosy 2023-2027 targets.
The World Health Organization (WHO) declared India had eliminated leprosy as a public health problem in 2005, but the government's complacency and the folding of the leprosy surveillance programme into the general health system allowed transmission to continue.
Why it matters
Leprosy, also known as Hansen's disease, is a chronic bacterial infection that can cause nerve damage, disability, and disfigurement if left untreated.
The continued transmission of leprosy in India is a concern, particularly among children, who accounted for around 46% of all cases reported among children in 2025.
What it means for you
The uneven disease burden across states, with Chhattisgarh, Jharkhand, Odisha, and Maharashtra bearing a disproportionate share of the national burden, means that some areas require more targeted interventions.
Additionally, the stigma surrounding leprosy can lead to delayed diagnosis and treatment, resulting in nerve damage and disability.
By the numbers
- 70 crore people were screened in highly endemic areas in 2025-26.
- 24,367 cases were detected in these areas.
- 40 lakh suspected cases were flagged by ASHA workers.
- 48,027 cases were confirmed.
- 91.1% of those likely to have come into contact with leprosy patients received single-dose rifampicin as post-exposure prophylaxis.
What happens next
The government has operationalised digital surveillance and is considering the use of the MIP vaccine to accelerate pathogen clearance in patients deemed highly infectious.
However, the state must resist the temptation to ease detection or revise its elimination targets and instead increase investments to meet the extant 2026-27 projections.
Experts emphasize the need for a multi-faceted approach, including improved awareness, enhanced healthcare infrastructure, and community engagement, to effectively combat leprosy transmission and achieve the NSP targets.
The government's commitment to leprosy elimination is crucial, and the implementation of effective strategies will be essential in reducing the disease burden and improving the lives of those affected.
Implications for readers in India
Readers in India should be aware of the ongoing leprosy transmission and the importance of early detection and treatment.
They can contribute to the efforts by supporting awareness campaigns, promoting community engagement, and advocating for improved healthcare infrastructure in endemic areas.
What to watch next
The progress of the NSP and the Roadmap for Leprosy 2023-2027 will be crucial in determining the effectiveness of India's leprosy elimination efforts.
Readers should watch for updates on the government's initiatives, the impact of digital surveillance, and the potential use of the MIP vaccine in accelerating pathogen clearance.
Expert Perspective
Experts highlight the need for sustained efforts to combat leprosy transmission, including improved awareness, enhanced healthcare infrastructure, and community engagement.
The government's commitment to leprosy elimination is crucial, and the implementation of effective strategies will be essential in reducing the disease burden and improving the lives of those affected.
Background
Leprosy, also known as Hansen's disease, is a chronic bacterial infection that has been present in India for centuries.
The disease has been a significant public health concern, with efforts to eliminate it dating back to the 1950s.
The WHO's declaration of India's elimination of leprosy as a public health problem in 2005 was a significant milestone, but the continued transmission of the disease highlights the need for sustained efforts.
Timeline
1950s: Leprosy elimination efforts begin in India.
2005: WHO declares India has eliminated leprosy as a public health problem.
2010s: Disability due to leprosy begins to rise, prompting door-to-door screening.
2023-2027: National Strategic Plan and Roadmap for Leprosy aim to eliminate the disease.
2025-26: Workers screen over 70 crore people, detecting 24,367 cases and confirming 48,027 cases.
Frequently Asked Questions
What is leprosy?
Leprosy, also known as Hansen's disease, is a chronic bacterial infection that can cause nerve damage, disability, and disfigurement if left untreated.
Why is leprosy a concern in India?
Leprosy is a concern in India due to ongoing transmission in many areas, uneven disease burden across states, and the stigma surrounding the disease.
What can readers in India do to contribute to leprosy elimination efforts?
Readers in India can contribute to the efforts by supporting awareness campaigns, promoting community engagement, and advocating for improved healthcare infrastructure in endemic areas.
